UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2022-05-30 雨落殇殇

偏重的研究方向：癌症
经验分享：实在是太慢了。。。半年了

44 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2023-10-08 ms1000001248501771 来自上海

请问近期有人投稿该期刊吗？可以分享一下进度嘛？

22 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2016-02-23 天天痘地主

审稿速度:3.0 | 投稿命中率:50.0
经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。

437 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2022-12-03 ms7000000368438856 来自上海

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2021-11-15 隔壁王校长

11-03投出，11-14Under Review
速度还挺快

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

投nature需要什么准备？

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2019-01-12 伊者

拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表:
请问您的文章后续有结果吗？

Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？

247 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2019-10-19 ericyelin

审稿速度:12.0 | 投稿命中率:50.0
经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。

172 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223294, encodeId=935212232947f, content=偏重的研究方向：癌症 经验分享：实在是太慢了。。。半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon May 30 07:52:58 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161574, encodeId=de1421615e42b, content=请问近期有人投稿该期刊吗？可以分享一下进度嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff378284152, createdName=ms1000001248501771, createdTime=Sun Oct 08 16:23:28 CST 2023, time=2023-10-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=519411, encodeId=ae2e519411e2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：杂志比较友好，编辑初步决定很快，是否拒稿或送审（一周内），under review 一般2个月左右就有结果。希望以后能重回3分水平。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb1f1651772, createdName=天天痘地主, createdTime=Tue Feb 23 08:58:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104064, encodeId=d620210406415, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问有大神知道，需要所有作者都要确认才会进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c80e5400552, createdName=ms7000000368438856, createdTime=Sat Dec 03 11:28:36 CST 2022, time=2022-12-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070424, encodeId=0a3e10e04242c, content=11-03投出，11-14Under Review 速度还挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Nov 15 14:38:47 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099772, encodeId=222c1099e72db, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099771, encodeId=ab371099e71e8, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565475, encodeId=2ab35654e520, content=拒稿再投，相当于大大修吧。三个好评，一个差评，被某国内的审稿人差评，明显带着情绪的那种，目前已经返修二审结束，decision in processLee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, beContent=Lee F 2018-12-26 00:00:00 发表: 请问您的文章后续有结果吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krvFxVLfVib83a42hsEVETUCtXjWOuVM1ia1UENdBiaAvttqJxVfkdENZQZwRVgvUPNAHfADepjQnibZb/0, createdBy=75c51927837, createdName=伊者, createdTime=Sat Jan 12 00:00:00 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578155, encodeId=fd105e815531, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：投了2篇：第一篇前列腺癌影像学临床研究，2019.3.18投稿，2019.7.15近4个月后第一次Decision，给了Minor Revision，3个审稿人的意见都很好，2019.7.18返回后2019.9月初（具体日期忘了）第二次修回仍是Minor Revision但却又找了另外三个审稿人，又提出了一大堆尖锐的问题，以为会挂了，2019.9.22 Response再次发回编辑部，这次不到1个月就出现Dicision in progress字样，还好，2019.10.18等来了Accept，整整7个月。第二篇上尿路肿瘤数据分析，2019.5.17投稿，2019.5.18拒稿，干脆利落，转投他刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a65930417, createdName=ericyelin, createdTime=Sat Oct 19 09:05:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580841, encodeId=0ae8580841b8, content=从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12835116023, createdName=146263b2m65暂无昵称, createdTime=Mon Dec 02 00:00:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]

2019-12-02 146263b2m65暂无昵称

从投稿到接受一共三个半月，一审时间很快，一个月不到给了大修，共两个审稿人，大大小小十多个意见，二审拖了一个半月给了小修修回半个月顺利接受

184 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务